Tacrolimus in CD3+ T Lymphocytes

计划入组 28 人 · 首次发布于 2024 年 4 月 2 日

BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis

计划入组 21 人 · 首次发布于 2025 年 9 月 3 日

BCMA/CD3 BsAb Therapy for POEMS Syndrome

计划入组 10 人 · 首次发布于 2025 年 8 月 11 日

TCR/CD3 (Salipro Biotech)

CDX/CD3

TCR-1

LION TCR PTE. LTD.

Singapore

Immatics

Germany

TScan Therapeutics

United States

T-Therapeutics Raises $91 Million Series A to Advance First-in-Class TCR-CD3 Bispecifics for Cancer and Autoimmune Disease

Flagship Pioneering and Repertoire Immune Medicines Partner with Pfizer to Develop TCR Bispecifics for Metastatic Prostate Cancer

Treeline and Roche Collaborate on Phase 1 Trial of BCL6 Degrader TLN-121 Combined with CD20×CD3 Bispecifics in B-Cell Lymphomas